Atherosclerosis

Publisher Elsevier

Description

Impact factor
4.29
ISSN
1879-1484

Publisher details

Elsevier

Pre-print:
Subject to restrictions below; author can archive a pre-print version
Restrictions
  • This does not include Cell Press
Post-print
Author can archive a post-print version
Conditions
  • On authors personal or authors institutions server
  • Published source must be acknowledged
  • Must link to journal home page
  • Publisher's version/PDF cannot be used
  • Articles in some journals can be made Open Access on payment of additional charge
  • NIH Authors articles will be submitted to PMC after 12 months.
Classification
green

Publications in this journal

  • Atherosclerosis and arterial stiffness in obstructive sleep apnea-A cardiovascular magnetic resonance study.

    Authors: Ilias Kylintireas, Sonya Craig, Richard Nethononda, Malcolm Kohler, Jane Francis, Robin Choudhury, John Stradling, Stefan Neubauer

    Atherosclerosis.

    OBJECTIVE: Obstructive sleep apnoea (OSA) has been linked to cardiovascular risk factors, such as hypertension, and clinical cardiovascular endpoints. Our aim was to assess whether OSA is
  • Pancreatic β-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus.

    Authors: Robin P F Dullaart, Wijtske Annema, Jan Freark de Boer, Uwe J F Tietge

    Atherosclerosis.

    BACKGROUND: High density lipoproteins (HDLs) have been implicated in glucose homeostasis. Among subjects with normal fasting glucose (NFG), impaired fasting glucose (IFG) and Type 2 diabetes mellitus
  • RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity.

    Authors: Weifang Yu, Ru Liu-Bryan, Stephanie Stevens, Jagadeesha K Damanahalli, Robert Terkeltaub

    Atherosclerosis.

    OBJECTIVE: Intima formation involves smooth muscle cell (SMC) proliferation and migration that ultimately drives arterial stenosis, thrombosis, and ischemia in atherosclerosis, hypertension, and
  • Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima fatty rats.

    Authors: Bolin Qin, Richard A Anderson, Teiji Kuzuya, Yasuyuki Kitaura, Yoshiharu Shimomura

    Atherosclerosis.

    AIMS: Overproduction of hepatic very low-density lipoprotein (VLDL) particles is a major abnormality of lipoprotein dysregulation in type 2 diabetes (T2D). We sought to examine the relationship
  • Dietary fatty acids and peripheral artery disease in adults.

    Authors: Asghar Z Naqvi, Roger B Davis, Kenneth J Mukamal

    Atherosclerosis.

    BACKGROUND: Peripheral artery disease (PAD) is a debilitating condition involving atherosclerosis. Although saturated, monounsaturated and polyunsaturated fatty acids have strong associations with
  • A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE.

    Authors: Olivier S Descamps, Marie Therese Cooney, Guy De Backer, Ian Graham

    Atherosclerosis.

    The 2011 ESC-EAS guidelines on the management of dyslipidaemias use four separate charts to illustrate the impact of differing HDL cholesterol levels on risk of cardiovascular disease. We developed
  • Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques.

    Authors: Jacob George, Shmuel Schwartzenberg, Diego Medvedovsky, Michael Jonas, Gideon Charach, Arnon Afek, Ari Shamiss

    Atherosclerosis.

    BACKGROUND: Despite having a similar large extent of atherosclerotic coronary affliction, some patients suffer of recurrent cardiac events, whereas others remain asymptomatic. HYPOTHESIS: We
  • YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes.

    Authors: Klaudija Batinic, Clemens Höbaus, Milan Grujicic, Angelika Steffan, Finka Jelic, David Lorant, Thomas Hörtenhuber, Florian Hoellerl, Johanna-Maria Brix, Guntram Schernthaner, Renate Koppensteiner, Gerit-Holger Schernthaner

    Atherosclerosis.

    OBJECTIVE: YKL-40 is secreted by macrophages in atherosclerotic lesions and involved in plaque rupture. YKL-40 is elevated in coronary artery disease, and predicts cardiovascular mortality.
  • Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals.

    Authors: Adenalva L S Beck, Maria E B Otto, Luciana B O D Avila, Fernando M Netto, Marinez K Armendaris, Andrei C Sposito

    Atherosclerosis.

    OBJECTIVE: Diastolic dysfunction (DD) is a frequent condition in hypertensive patients whose presence increases mortality and whose treatment remains unclear. The aim of this study was to investigate
  • Carotid extra-medial thickness in childhood: Early life effects on the arterial adventitia.

    Authors: Michael R Skilton, Tim R Sullivan, Julian G Ayer, Jason A Harmer, Brett G Toelle, Karen Webb, Guy B Marks, David S Celermajer

    Atherosclerosis.

    OBJECTIVE: Structural modification of the arterial adventitia may be an early event in atherosclerosis. Carotid extra-medial thickness is a new measure of arterial adventitial thickness. We examined
  • Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players.

    Authors: Salim S Virani, Lisa Pompeii, Andrew E Lincoln, Reginald E Dunn, Andrew M Tucker, Vijay Nambi, Khurram Nasir, Robert A Vogel, Jeffrey L Boone, Arthur J Roberts, Christie M Ballantyne

    Atherosclerosis.

    OBJECTIVES: We assessed whether low-density lipoprotein particle concentration (LDL-P) and high-sensitivity C-reactive protein [hs-CRP] can identify subclinical atherosclerosis better than
  • Assessment of the value of a genetic risk score in improving the estimation of coronary risk.

    Authors: Carla Lluis-Ganella, Isaac Subirana, Gavin Lucas, Marta Tomás, Daniel Muñoz, Mariano Sentí, Eduardo Salas, Joan Sala, Rafel Ramos, Jose M Ordovas, Jaume Marrugat, Roberto Elosua

    Atherosclerosis.

    BACKGROUND: The American Heart Association has established criteria for the evaluation of novel markers of cardiovascular risk. In accordance with these criteria, we assessed the association between
  • Estimation of lipoprotein profile in patients with type II diabetes and its relevance to remnant lipoprotein cholesterol levels.

    Authors: Hiroshi Yoshida, Yuji Hirowatari, Hideo Kurosawa, Daisuke Manita, Hidekatsu Yanai, Kumie Ito, Norio Tada

    Atherosclerosis.

    BACKGROUND: Remnant lipoprotein (RLP), associated with atherosclerosis progression, is often elevated in diabetes mellitus. The RLP level is estimated by immune-separation method and agarose-gel
  • IL-1, quo vadis?

    Authors: Alena Grebe, Eicke Latz

    Atherosclerosis.

  • PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.

    Authors: Shi-Lin Tang, Wu-Jun Chen, Kai Yin, Guo-Jun Zhao, Zhong-Cheng Mo, Yun-Cheng Lv, Xin-Ping Ouyang, Xiao-Hua Yu, Huai-Jun Kuang, Zhi-Sheng Jiang, Yu-Chang Fu, Chao-Ke Tang

    Atherosclerosis.

    Pregnancy-associated plasma protein-A (PAPP-A) has been involved in the atherosclerotic process through regulation of local expression of IGF-1 that mediates the activation of the
  • Evaluation of possible subclinical atherosclerosis in adolescents with a family history of premature atherosclerosis.

    Authors: Atac Celik, Mustafa Ozcetin, Zekiye Ruken Yuksekkaya Celikyay, Erkan Sogut, Yasemin Yerli, Hasan Kadi, Fatih Koc, Ibrahim Halil Damar, Koksal Ceyhan, Unal Erkorkmaz

    Atherosclerosis.

    OBJECTIVE: To evaluate possible subclinical atherosclerosis using biomarkers and ultrasound-guided methods in a group of adolescents having fathers with premature atherosclerosis. METHODS:
  • Aortic stiffness and calcification in men in a population-based international study.

    Authors: Akira Sekikawa, Chol Shin, J David Curb, Emma Barinas-Mitchell, Kamal Masaki, Aiman El-Saed, Todd B Seto, Rachel H Mackey, Jina Choo, Akira Fujiyoshi, Katsuyuki Miura, Daniel Edmundowicz, Lewis H Kuller, Hirotsugu Ueshima, Kim Sutton-Tyrrell

    Atherosclerosis.

    OBJECTIVES: Aortic stiffness, a hallmark of vascular aging, is an independent risk factor of cardiovascular disease and all-cause mortality. The association of aortic stiffness with aortic
  • Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.

    Authors: Danna M Breen, Vernon W Dolinsky, Hangjun Zhang, Husam Ghanim, June Guo, Margaret Mroziewicz, Evangelia L Tsiani, Michelle P Bendeck, Paresh Dandona, Jason R B Dyck, Scott P Heximer, Adria Giacca

    Atherosclerosis.

    Revascularization procedures used for treatment of atherosclerosis often result in restenosis. Resveratrol (RSV), an antioxidant with cardiovascular benefits, decreases neointimal formation after
  • Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.

    Authors: Katherine N Theken, Robert N Schuck, Matthew L Edin, Bryant Tran, Kyle Ellis, Almasa Bass, Fred B Lih, Kenneth B Tomer, Samuel M Poloyac, Michael C Wu, Alan L Hinderliter, Darryl C Zeldin, George A Stouffer, Craig R Lee

    Atherosclerosis.

    OBJECTIVE: Preclinical and genetic epidemiologic studies suggest that modulating cytochrome P450 (CYP)-mediated arachidonic acid metabolism may have therapeutic utility in the management of coronary
  • Follow-up association study of linkage regions reveals multiple candidate genes for carotid plaque in Dominicans.

    Authors: Chuanhui Dong, Ashley Beecham, Liyong Wang, Susan H Blanton, Tatjana Rundek, Ralph L Sacco

    Atherosclerosis.

    OBJECTIVE: Carotid plaque is a marker of subclinical atherosclerosis with a genetic component. The aim of this follow-up fine mapping study was to identify candidate genes for carotid plaque within
  • Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages.

    Authors: Wenquan Hu, Xiaoye Zhou, Meixiu Jiang, Yajun Duan, Yuanli Chen, Xiaoju Li, Zhinan Yin, Guo-Wei He, Zhi Yao, Yan Zhu, David P Hajjar, Jihong Han

    Atherosclerosis.

    OBJECTIVE: Macrophage adipocyte fatty acid binding protein (FABP4) plays an important role in the development of atherosclerosis. We previously reported that dexamethasone induces macrophage FABP4
  • Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency.

    Authors: Monica S Rocha, Tom Teerlink, Mirian C H Janssen, Leo A J Kluijtmans, Yvo Smulders, Cornelis Jakobs, Isabel Tavares de Almeida, Isabel Rivera, Rita Castro, Henk J Blom

    Atherosclerosis.

    In hyperhomocysteinemia (HHcy), an independent risk factor for cardiovascular diseases, endothelial dysfunction due to reduced bioavailability of nitric oxide is a consistent finding. However, the
  • Advances in cell-based therapy for peripheral vascular disease.

    Authors: Arnon Blum, Wayne Balkan, Joshua M Hare

    Atherosclerosis.

    Evidence is accumulating to support cell-based therapies as a new approach for chronic diseases. Perhaps the area of greatest impact, in terms of patient numbers, is cardiovascular disorders. This
Follow

Keywords

atherosclerosi
 
cholesterol
 
coronari
 
crp
 
diseas
 
factor
 
hdl
 
insulin
 
level
 
p
 
risk
 
serum
 
statin
 
syndrom
 
were
 

Related Journals